相似文献
1
Immunity against tularemia: passive protection of mice by transfer of immune tissues.
J Exp Med. 1962 Feb 1;115(2):411-20. doi: 10.1084/jem.115.2.411.
2
Murine model for study of cell-mediated immunity: protection against death from fully virulent Francisella tularensis infection.
Infect Immun. 1975 Nov;12(5):999-1005. doi: 10.1128/iai.12.5.999-1005.1975.
3
Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance.
Microb Pathog. 1987 Jan;2(1):3-14. doi: 10.1016/0882-4010(87)90110-0.
4
Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
Microb Pathog. 2012 Nov-Dec;53(5-6):259-68. doi: 10.1016/j.micpath.2012.07.006. Epub 2012 Jul 25.
5
Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
Vaccine. 2007 May 10;25(19):3781-91. doi: 10.1016/j.vaccine.2007.02.014. Epub 2007 Feb 26.
6
Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
Microbiol Immunol. 2018 Jan;62(1):24-33. doi: 10.1111/1348-0421.12555. Epub 2018 Jan 1.
7
Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
Clin Vaccine Immunol. 2015 Jan;22(1):119-28. doi: 10.1128/CVI.00648-14. Epub 2014 Nov 19.
8
Immunological markers that correlate with protection immunity against tularemia infection.
Adv Exp Med Biol. 2014;808:15-23. doi: 10.1007/978-81-322-1774-9_2.
9
Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
Vaccine. 2017 Dec 15;35(50):7001-7009. doi: 10.1016/j.vaccine.2017.10.053. Epub 2017 Nov 6.
10
Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
Vaccine. 2004 Jun 2;22(17-18):2116-21. doi: 10.1016/j.vaccine.2003.12.003.
引用本文的文献
1
Differential Immune Response Following Intranasal and Intradermal Infection with Implications for Vaccine Development.
Microorganisms. 2021 Apr 30;9(5):973. doi: 10.3390/microorganisms9050973.
2
Development of a novel Francisella tularensis Live Vaccine Strain expressing ovalbumin provides insight into antigen-specific CD8+ T cell responses.
PLoS One. 2017 Dec 28;12(12):e0190384. doi: 10.1371/journal.pone.0190384. eCollection 2017.
3
Francisella philomiragia Infection and Lethality in Mammalian Tissue Culture Cell Models, Galleria mellonella, and BALB/c Mice.
Front Microbiol. 2016 May 24;7:696. doi: 10.3389/fmicb.2016.00696. eCollection 2016.
4
Immunotherapy for tularemia.
Virulence. 2013 Nov 15;4(8):859-70. doi: 10.4161/viru.25454. Epub 2013 Jun 19.
5
Human body temperature and new approaches to constructing temperature-sensitive bacterial vaccines.
Cell Mol Life Sci. 2011 Sep;68(18):3019-31. doi: 10.1007/s00018-011-0734-2. Epub 2011 May 31.
6
Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains.
Infect Immun. 2011 Apr;79(4):1770-8. doi: 10.1128/IAI.00605-10. Epub 2011 Jan 31.
7
Temperature-sensitive bacterial pathogens generated by the substitution of essential genes from cold-loving bacteria: potential use as live vaccines.
J Mol Med (Berl). 2011 May;89(5):437-44. doi: 10.1007/s00109-010-0721-3. Epub 2011 Jan 13.
8
Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.
Clin Vaccine Immunol. 2009 Mar;16(3):414-22. doi: 10.1128/CVI.00362-08. Epub 2009 Jan 28.
9
Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.
Infect Immun. 2008 Feb;76(2):486-96. doi: 10.1128/IAI.00862-07. Epub 2007 Nov 19.
10
Virulence of Francisella spp. in chicken embryos.
Infect Immun. 2006 Aug;74(8):4809-16. doi: 10.1128/IAI.00034-06.
本文引用的文献
1
STUDIES ON THE MECHANISM OF IMMUNITY IN TUBERCULOSIS : THE FATE OF TUBERCLE BACILLI INGESTED BY MONONUCLEAR PHAGOCYTES DERIVED FROM NORMAL AND IMMUNIZED ANIMALS.
J Exp Med. 1942 Mar 1;75(3):247-68. doi: 10.1084/jem.75.3.247.
2
ANTITULARENSE SERUM: CORRELATION BETWEEN PROTECTIVE CAPACITY FOR WHITE RATS AND PRECIPITABLE ANTIBODY CONTENT.
J Clin Invest. 1947 Jul;26(4):756-60. doi: 10.1172/JCI101858.
3
4
Studies on chemotherapy of vaccinia virus. I. An experimental design for testing antiviral agents.
J Bacteriol. 1951 Feb;61(2):127-34. doi: 10.1128/jb.61.2.127-134.1951.
5
Passive transfer of resistance to tuberculosis through use of monocytes.
Proc Soc Exp Biol Med. 1960 Feb;103:326-9. doi: 10.3181/00379727-103-25506.
6
7
Tularemia vaccine study. II. Respiratory challenge.
Arch Intern Med. 1961 May;107:702-14. doi: 10.1001/archinte.1961.03620050068007.
8
A cellular basis of immunity in experimental Brucella infection.
J Exp Med. 1958 Sep 1;108(3):343-60. doi: 10.1084/jem.108.3.343.
9
New medium for the cultivation of Pasteurella tularensis.
J Bacteriol. 1958 Feb;75(2):237-9. doi: 10.1128/jb.75.2.237-239.1958.
10
Intracellular multiplication of Brucella abortus in normal and immune mononuclear phagocytes.
Proc Soc Exp Biol Med. 1957 Jan;94(1):78-83. doi: 10.3181/00379727-94-22860.
Zotero 插件